Free Trial

TransCode Therapeutics (RNAZ) Short Interest Ratio & Short Volume

$1.44
+0.19 (+15.20%)
(As of 05/22/2024 ET)

TransCode Therapeutics Short Interest Data

Current Short Interest
149,600 shares
Previous Short Interest
18,600 shares
Change Vs. Previous Month
+704.30%
Dollar Volume Sold Short
$90,822.16
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
6,620,000 shares
Float Size
6,540,000 shares
Short Percent of Float
2.29%
Today's Trading Volume
1,609,346 shares
Average Trading Volume
2,867,084 shares
Today's Volume Vs. Average
56%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TransCode Therapeutics ?

Sign up to receive the latest short interest report for TransCode Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RNAZ Short Interest Over Time

RNAZ Days to Cover Over Time

RNAZ Percentage of Float Shorted Over Time

TransCode Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024149,600 shares $90,822.16 +704.3%2.3%0.2 $0.61
4/15/202418,600 shares $9,975.18 -53.5%0.3%0 $0.54
3/31/202440,000 shares $27,320.00 -77.1%0.6%0.1 $0.68
3/15/2024174,800 shares $120,786.80 +71.4%2.7%0.3 $0.69
2/29/2024102,000 shares $71,869.20 -53.8%1.6%0.2 $0.70
2/15/2024220,900 shares $145,794.00 -70.8%3.4%0.4 $0.66
1/31/2024755,300 shares $521,912.30 +7,529.3%13.0%1.6 $0.69
1/15/20249,900 shares $49,500.00 -97.6%1.8%0 $5.00
12/31/2023405,000 shares $66,744.00 -7.4%N/A0.1 $0.16
12/15/2023437,500 shares $74,156.25 -31.3%2.0%0.1 $0.17
11/30/2023637,200 shares $156,751.20 +31.8%3.0%0.1 $0.25
11/15/2023483,300 shares $138,610.44 -63.4%2.5%0.1 $0.29
10/31/20231,320,000 shares $488,664.00 +562.0%7.4%0.2 $0.37
10/15/2023199,400 shares $86,100.92 +173.9%6.2%0 $0.43
9/30/202372,800 shares $36,596.56 -42.4%4.5%0 $0.50
9/15/2023126,400 shares $84,511.04 +418.0%7.1%0.1 $0.67
8/31/202324,400 shares $35,380.00 +1,255.6%1.7%0.2 $1.45
8/15/20231,800 shares $2,916.00 -87.8%0.1%0 $1.62
7/31/202314,700 shares $32,340.00 -85.5%2.5%0.1 $2.20
7/15/2023101,500 shares $257,810.00 +81.9%16.9%0.4 $2.54
6/30/202355,800 shares $128,340.00 +14.6%9.3%0.2 $2.30
6/15/202348,700 shares $129,055.00 +79.7%8.1%0.2 $2.65
5/31/202327,100 shares $113,820.00 +22.1%4.4%0.2 $4.20
5/15/202322,200 shares $135,109.20 -96.6%N/A0.5 $6.09
4/30/2023653,200 shares $206,345.88 +2.7%5.6%0.4 $0.32
4/15/2023636,000 shares $250,965.60 +99.5%5.5%0.4 $0.39
3/31/2023318,800 shares $107,913.80 +21.0%2.8%0.2 $0.34
3/15/2023263,500 shares $91,618.95 -51.3%2.3%0.2 $0.35
2/28/2023541,400 shares $282,069.40 -42.9%4.7%0.1 $0.52
2/15/2023948,400 shares $635,428.00 +104.5%7.5%0.2 $0.67
1/31/2023463,700 shares $348,145.96 +0.8%5.3%0.2 $0.75
1/15/2023459,900 shares $281,458.80 -43.5%5.3%0.1 $0.61
12/30/2022814,100 shares $547,889.30 -22.5%9.4%0.3 $0.67
12/15/20221,050,000 shares $472,290.00 +2,849.4%12.1%0.4 $0.45
11/30/202235,600 shares $14,240.00 +368.4%0.4%0 $0.40
11/15/20227,600 shares $4,164.80 -96.5%0.1%0 $0.55
10/31/2022218,800 shares $147,033.60 +478.8%2.5%0.3 $0.67
10/15/202237,800 shares $41,995.80 -2.1%0.4%1.9 $1.11
9/30/202238,600 shares $42,460.00 +565.5%0.4%1.9 $1.10
9/15/20225,800 shares $6,728.00 -29.3%0.1%0.3 $1.16
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (Ad)

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.
8/31/20228,200 shares $9,840.00 +90.7%0.1%0.2 $1.20
8/15/20224,300 shares $5,547.00 -66.4%0.1%0.1 $1.29
7/31/202212,800 shares $18,176.00 +1.6%0.2%0.3 $1.42
7/15/202212,600 shares $16,632.00 +26.0%0.1%0.3 $1.32
6/30/202210,000 shares $12,600.00 +1.0%0.1%0.2 $1.26
6/15/20229,900 shares $12,573.00 -52.9%0.1%0.3 $1.27
5/31/202221,000 shares $38,640.00 -15.7%0.2%1.1 $1.84
5/15/202224,900 shares $56,025.00 -46.6%0.3%1.5 $2.25
4/30/202246,600 shares $127,218.00 +88.7%0.5%2.9 $2.73
4/15/202224,700 shares $70,814.90 -44.9%0.3%1.4 $2.87
3/31/202244,800 shares $129,024.00 +37.9%0.5%2 $2.88
3/15/202232,500 shares $70,200.00 -38.2%0.4%0.9 $2.16
2/28/202252,600 shares $112,038.00 -37.8%0.7%1.3 $2.13
2/15/202284,600 shares $181,044.00 -12.6%1.2%1.6 $2.14
1/31/202296,800 shares $222,640.00 -24.7%1.4%1.6 $2.30
1/15/2022128,500 shares $322,535.00 +51.4%1.8%1.6 $2.51
12/31/202184,900 shares $215,646.00 +0.7%1.2%0.7 $2.54
12/15/202184,300 shares $207,378.00 +157.0%1.2%0.3 $2.46
11/30/202132,800 shares $90,200.00 +32.8%0.5%0 $2.75
11/15/202124,700 shares $73,606.00 -86.7%0.4%0 $2.98
10/29/2021185,900 shares $526,097.00 -22.9%2.6%0 $2.83
10/15/2021241,100 shares $776,342.00 -47.1%3.4%0.1 $3.22
9/30/2021455,400 shares $1.36 million +1,350.3%6.4%0.1 $2.99
9/15/202131,400 shares $81,012.00 -39.7%0.4%0 $2.58
8/31/202152,100 shares $158,384.00 +128.5%0.7%0 $3.04
8/13/202122,800 shares $65,436.00 No Change0.4%0 $2.87

RNAZ Short Interest - Frequently Asked Questions

What is TransCode Therapeutics' current short interest?

Short interest is the volume of TransCode Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 149,600 shares of RNAZ short. 2.29% of TransCode Therapeutics' shares are currently sold short. Learn More on TransCode Therapeutics' current short interest.

What is a good short interest percentage for TransCode Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.29% of TransCode Therapeutics' floating shares are currently sold short.

Is TransCode Therapeutics' short interest increasing or decreasing?

TransCode Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 149,600 shares, an increase of 704.3% from the previous total of 18,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TransCode Therapeutics' float size?

TransCode Therapeutics currently has issued a total of 6,620,000 shares. Some of TransCode Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TransCode Therapeutics currently has a public float of 6,540,000 shares.

How does TransCode Therapeutics' short interest compare to its competitors?

2.29% of TransCode Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TransCode Therapeutics: Vaccinex, Inc. (2.40%), ASLAN Pharmaceuticals Limited (4.12%), GT Biopharma, Inc. (0.48%), Trevena, Inc. (0.08%), Chemomab Therapeutics Ltd. (0.98%), Mainz Biomed (2.57%), Alterity Therapeutics Limited (1.03%), First Wave BioPharma, Inc. (2.39%), Addex Therapeutics Ltd (1.85%), Pulmatrix, Inc. (0.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short TransCode Therapeutics stock?

Short selling RNAZ is an investing strategy that aims to generate trading profit from TransCode Therapeutics as its price is falling. RNAZ shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TransCode Therapeutics?

A short squeeze for TransCode Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNAZ, which in turn drives the price of the stock up even further.

How often is TransCode Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNAZ, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RNAZ) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners